Relmada Therapeutics (RLMD) Amortizatization of Intangibles (2014 - 2019)
Relmada Therapeutics' (RLMD) quarterly Amortizatization of Intangibles came in at $1.0 in Q2 2019, down 100.0% year-on-year from $527980.0 in Q2 2018, and down 100.0% on a QoQ basis from $124647.0 in Q4 2018.
Relmada Therapeutics (RLMD) Amortizatization of Intangibles (2014 - 2019) Analysis & Trends
Relmada Therapeutics (RLMD) has 4 years of Amortizatization of Intangibles data on file, last reported at $1.0 in Q2 2019.
- On a quarterly basis, Amortizatization of Intangibles fell 100.0% year-over-year to $1.0 in Q2 2019; TTM through Jun 2019 was $661168.0, a 35.76% decrease from a year earlier, with the FY2019 full-year figure at $661168.0, down 35.76% from the prior year.
- Amortizatization of Intangibles for Q2 2019 stood at $1.0, down from $124647.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for RLMD reached as high as $536520.0 in Q3 2018 and fell as low as $1.0 in Q2 2019.
- Historically, Amortizatization of Intangibles has averaged $241478.7 across 3 years, with a median of $204962.0 in 2017.
- Across the five-year window, Amortizatization of Intangibles surged 18932.28% in 2018 and plunged 100.0% in 2019, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $204962.0 in 2017, then sank by 39.19% to $124647.0 in 2018, then plunged by 100.0% to $1.0 in 2019.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $1.0 in Q2 2019, $124647.0 in Q4 2018, and $536520.0 in Q3 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Relmada Therapeutics | 452.90 Mn | 452.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 1.00 |
| Jun 30, 2019 | 1.00 |
| Dec 31, 2018 | 124,647.00 |
| Dec 31, 2018 | 124,647.00 |
| Sep 30, 2018 | 536,520.00 |
| Sep 30, 2018 | 536,520.00 |
| Jun 30, 2018 | 527,980.00 |
| Jun 30, 2018 | 527,980.00 |
| Mar 31, 2018 | 293,422.00 |
| Mar 31, 2018 | 293,422.00 |
| Dec 31, 2017 | 204,962.00 |
| Dec 31, 2017 | 204,962.00 |
| Sep 30, 2017 | 2,819.00 |
| Sep 30, 2017 | 2,819.00 |
| Jun 30, 2014 | 327,776.00 |
| Jun 30, 2014 | 327,776.00 |
| Mar 31, 2014 | 172,818.00 |
| Mar 31, 2014 | 172,818.00 |